170 related articles for article (PubMed ID: 36144591)
1. Identification of Gedunin from a Phytochemical Depository as a Novel Multidrug Resistance-Bypassing Tubulin Inhibitor of Cancer Cells.
Khalid SA; Dawood M; Boulos JC; Wasfi M; Drif A; Bahramimehr F; Shahhamzehei N; Shan L; Efferth T
Molecules; 2022 Sep; 27(18):. PubMed ID: 36144591
[TBL] [Abstract][Full Text] [Related]
2. Molecular Modes of Action of an Aqueous
Rashan LJ; Özenver N; Boulos JC; Dawood M; Roos WP; Franke K; Papasotiriou I; Wessjohann LA; Fiebig HH; Efferth T
Molecules; 2023 Feb; 28(4):. PubMed ID: 36838857
[TBL] [Abstract][Full Text] [Related]
3. Gedunin modulates cellular growth and apoptosis in glioblastoma cell lines.
Stouffer M; Wandling E; Dickson L; Lin S; Duan H; Powe E; Jean-Louis D; Tiwari AK; Amos S
Cancer Rep (Hoboken); 2024 May; 7(5):e2051. PubMed ID: 38702989
[TBL] [Abstract][Full Text] [Related]
4. Activity of the dietary flavonoid, apigenin, against multidrug-resistant tumor cells as determined by pharmacogenomics and molecular docking.
Saeed M; Kadioglu O; Khalid H; Sugimoto Y; Efferth T
J Nutr Biochem; 2015 Jan; 26(1):44-56. PubMed ID: 25459885
[TBL] [Abstract][Full Text] [Related]
5. CKT0353, a novel microtubule targeting agent, overcomes paclitaxel induced resistance in cancer cells.
Dinić J; Ríos-Luci C; Karpaviciene I; Cikotiene I; Fernandes MX; Pešić M; Padrón JM
Invest New Drugs; 2020 Jun; 38(3):584-598. PubMed ID: 31177401
[TBL] [Abstract][Full Text] [Related]
6. Tivantinib (ARQ 197) exhibits antitumor activity by directly interacting with tubulin and overcomes ABC transporter-mediated drug resistance.
Aoyama A; Katayama R; Oh-Hara T; Sato S; Okuno Y; Fujita N
Mol Cancer Ther; 2014 Dec; 13(12):2978-90. PubMed ID: 25313010
[TBL] [Abstract][Full Text] [Related]
7. Cytotoxicity of South-African medicinal plants towards sensitive and multidrug-resistant cancer cells.
Saeed MEM; Meyer M; Hussein A; Efferth T
J Ethnopharmacol; 2016 Jun; 186():209-223. PubMed ID: 27058630
[TBL] [Abstract][Full Text] [Related]
8. Novel microtubule-targeting agents, pyrrolo-1,5-benzoxazepines, induce apoptosis in multi-drug-resistant cancer cells.
Nathwani SM; Butler S; Fayne D; McGovern NN; Sarkadi B; Meegan MJ; Lloyd DG; Campiani G; Lawler M; Williams DC; Zisterer DM
Cancer Chemother Pharmacol; 2010 Aug; 66(3):585-96. PubMed ID: 20020128
[TBL] [Abstract][Full Text] [Related]
9. Collateral sensitivity of natural products in drug-resistant cancer cells.
Efferth T; Saeed MEM; Kadioglu O; Seo EJ; Shirooie S; Mbaveng AT; Nabavi SM; Kuete V
Biotechnol Adv; 2020; 38():107342. PubMed ID: 30708024
[TBL] [Abstract][Full Text] [Related]
10. A novel class of tubulin inhibitors that exhibit potent antiproliferation and in vitro vessel-disrupting activity.
Meng F; Cai X; Duan J; Matteucci MG; Hart CP
Cancer Chemother Pharmacol; 2008 May; 61(6):953-63. PubMed ID: 17639393
[TBL] [Abstract][Full Text] [Related]
11. Pharmacogenomics of Scopoletin in Tumor Cells.
Seo EJ; Saeed M; Law BY; Wu AG; Kadioglu O; Greten HJ; Efferth T
Molecules; 2016 Apr; 21(4):496. PubMed ID: 27092478
[TBL] [Abstract][Full Text] [Related]
12. Cytotoxicity of the indole alkaloid reserpine from Rauwolfia serpentina against drug-resistant tumor cells.
Abdelfatah SA; Efferth T
Phytomedicine; 2015 Feb; 22(2):308-18. PubMed ID: 25765838
[TBL] [Abstract][Full Text] [Related]
13. BZML, a novel colchicine binding site inhibitor, overcomes multidrug resistance in A549/Taxol cells by inhibiting P-gp function and inducing mitotic catastrophe.
Bai Z; Gao M; Zhang H; Guan Q; Xu J; Li Y; Qi H; Li Z; Zuo D; Zhang W; Wu Y
Cancer Lett; 2017 Aug; 402():81-92. PubMed ID: 28576750
[TBL] [Abstract][Full Text] [Related]
14. Cytotoxicity of the bisphenolic honokiol from Magnolia officinalis against multiple drug-resistant tumor cells as determined by pharmacogenomics and molecular docking.
Saeed M; Kuete V; Kadioglu O; Börtzler J; Khalid H; Greten HJ; Efferth T
Phytomedicine; 2014 Oct; 21(12):1525-33. PubMed ID: 25442261
[TBL] [Abstract][Full Text] [Related]
15. SKLB060 Reversibly Binds to Colchicine Site of Tubulin and Possesses Efficacy in Multidrug-Resistant Cell Lines.
Yan W; Yang T; Yang J; Wang T; Yu Y; Wang Y; Chen Q; Bai P; Li D; Ye H; Qiu Q; Zhou Y; Hu Y; Yang S; Wei Y; Li W; Chen L
Cell Physiol Biochem; 2018; 47(2):489-504. PubMed ID: 29794416
[TBL] [Abstract][Full Text] [Related]
16. Pharmacogenomic Characterization of Cytotoxic Compounds from Salvia officinalis in Cancer Cells.
Kadioglu O; Efferth T
J Nat Prod; 2015 Apr; 78(4):762-75. PubMed ID: 25713926
[TBL] [Abstract][Full Text] [Related]
17. Multidrug resistance: retrospect and prospects in anti-cancer drug treatment.
Pérez-Tomás R
Curr Med Chem; 2006; 13(16):1859-76. PubMed ID: 16842198
[TBL] [Abstract][Full Text] [Related]
18. 5-(3,4,5-trimethoxybenzoyl)-4-methyl-2-(p-tolyl) imidazol (BZML) targets tubulin and DNA to induce anticancer activity and overcome multidrug resistance in colorectal cancer cells.
Bai Z; Liu X; Guan Q; Ding N; Wei Q; Tong B; Zhao M; Zhang W; Ma L
Chem Biol Interact; 2020 Jan; 315():108886. PubMed ID: 31682804
[TBL] [Abstract][Full Text] [Related]
19. Identification of pyrrolopyrimidine derivative PP-13 as a novel microtubule-destabilizing agent with promising anticancer properties.
Gilson P; Josa-Prado F; Beauvineau C; Naud-Martin D; Vanwonterghem L; Mahuteau-Betzer F; Moreno A; Falson P; Lafanechère L; Frachet V; Coll JL; Fernando Díaz J; Hurbin A; Busser B
Sci Rep; 2017 Aug; 7(1):10209. PubMed ID: 28860487
[TBL] [Abstract][Full Text] [Related]
20. Predicting drug sensitivity and resistance: profiling ABC transporter genes in cancer cells.
Szakács G; Annereau JP; Lababidi S; Shankavaram U; Arciello A; Bussey KJ; Reinhold W; Guo Y; Kruh GD; Reimers M; Weinstein JN; Gottesman MM
Cancer Cell; 2004 Aug; 6(2):129-37. PubMed ID: 15324696
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
